← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 31, 2011Last known activity
May 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 7 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (18)
- NCT05675098Overall official - principal investigatorEarly Phase 1May 1, 2023
- NCT05675098Reponsible party - principal investigatorEarly Phase 1May 1, 2023
- NCT05675098Lead sponsorEarly Phase 1May 1, 2023
- NCT04604223CollaboratorPhase 4Nov 15, 2020
- NCT04123002Reponsible party - principal investigatorN/AApr 1, 2019
- NCT04123002CollaboratorN/AApr 1, 2019
- NCT02771704Lead sponsorN/AOct 31, 2015
- NCT02771704Overall official - principal investigatorN/AOct 31, 2015
- NCT02771704Reponsible party - principal investigatorN/AOct 31, 2015
- NCT02444182Reponsible party - principal investigatorPhase 1/Phase 2Dec 1, 2014
- NCT02444182Lead sponsorPhase 1/Phase 2Dec 1, 2014
- NCT02444182Overall official - principal investigatorPhase 1/Phase 2Dec 1, 2014
- NCT01528969Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2012
- NCT01528969Lead sponsorPhase 1/Phase 2Mar 1, 2012
- NCT01528969Reponsible party - principal investigatorPhase 1/Phase 2Mar 1, 2012
Details
- Last known activity
- May 1, 2023